Close Menu

NEW YORK – Enzo Biochem reported after the close of the markets on Tuesday that its fiscal first quarter 2020 revenues fell 5 percent year over year, largely due to a decline in clinical services revenues.

For the three months ended Oct. 31, 2019, the company reported total revenues of $20.2 million, down from $21.3 million in the year-ago period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.